Ayala Pharmaceuticals Inc (ADXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-2022 | 09-2022 | 07-2022 | 06-2022 | 04-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | 28,150 | N/A | 32,085 |
| TOTAL | $N/A | $N/A | $29,817 | $N/A | $34,177 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 73 | N/A | 84 |
| Intangibles | 110 | 0 | 181 | 0 | 3,220 |
| Other Non-Current Assets | -110 | 0 | 30 | 0 | 37 |
| TOTAL | $N/A | $N/A | $284 | $N/A | $3,341 |
| Total Assets | $N/A | $N/A | $30,101 | $N/A | $37,518 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 90 | 0 | 39 |
| Accrued Expenses | N/A | N/A | 1,510 | N/A | 1,738 |
| Other current liabilities | 119 | N/A | 287 | N/A | 563 |
| TOTAL | $N/A | $N/A | $1,906 | $N/A | $2,367 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $N/A | $1,906 | $N/A | $2,367 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,838 | N/A | 1,816 | N/A | 1,820 |
| Common Shares | N/A | N/A | 2 | N/A | 2 |
| Retained earnings | N/A | N/A | -438,368 | N/A | -431,405 |
| TOTAL | $N/A | $N/A | $28,195 | $N/A | $35,151 |
| Total Liabilities And Equity | $0 | $0 | $30,101 | $0 | $37,518 |